Abstract

The mammalian target of rapamycin (mTOR) Ser/Thr kinase signals in at least two multiprotein complexes distinguished by their different partners and sensitivities to rapamycin. Acute rapamycin inhibits signaling by mTOR complex 1 (mTORC1) but not mTOR complex 2 (mTORC2), which both promote cell growth, proliferation, and survival. Although mTORC2 regulation remains poorly defined, diverse cellular mitogens activate mTORC1 signaling in a manner that requires sufficient levels of amino acids and cellular energy. Before the identification of distinct mTOR complexes, mTOR was reported to autophosphorylate on Ser-2481 in vivo in a rapamycin- and amino acid-insensitive manner. These results suggested that modulation of mTOR intrinsic catalytic activity does not universally underlie mTOR regulation. Here we re-examine the regulation of mTOR Ser-2481 autophosphorylation (Ser(P)-2481) in vivo by studying mTORC-specific Ser(P)-2481 in mTORC1 and mTORC2, with a primary focus on mTORC1. In contrast to previous work, we find that acute rapamycin and amino acid withdrawal markedly attenuate mTORC1-associated mTOR Ser(P)-2481 in cycling cells. Although insulin stimulates both mTORC1- and mTORC2-associated mTOR Ser(P)-2481 in a phosphatidylinositol 3-kinase-dependent manner, rapamycin acutely inhibits insulin-stimulated mTOR Ser(P)-2481 in mTORC1 but not mTORC2. By interrogating diverse mTORC1 regulatory input, we find that without exception mTORC1-activating signals promote, whereas mTORC1-inhibitory signals decrease mTORC1-associated mTOR Ser(P)-2481. These data suggest that mTORC1- and likely mTORC2-associated mTOR Ser-2481 autophosphorylation directly monitors intrinsic mTORC-specific catalytic activity and reveal that rapamycin inhibits mTORC1 signaling in vivo by reducing mTORC1 catalytic activity.

Highlights

  • The evolutionarily conserved mammalian target of rapamycin4 protein kinase functions as an environmental sensor, integrating signals from diverse cellular stimuli to control cellular physiology [1,2,3]. mTOR signals in at least two distinct multiprotein complexes distinguished by their partner proteins and differing sensitivities to rapamycin, a clinically employed immunosuppressive drug and allosteric mTOR inhibitor [4, 5]

  • Rapamycin Inhibits mTOR complex 1 (mTORC1) but Not mTOR complex 2 (mTORC2)-associated mTOR Ser-2481 Autophosphorylation in Response to Insulin/ PI3K Signaling—While immunoblotting whole cell lysates derived from 3T3-L1 adipocytes, we were surprised to observe that pretreatment of cells with rapamycin, an mTORC1-specific inhibitor, reduced insulin-stimulated mTOR Ser-2481 autophosphorylation (Ser(P)-2481)

  • Moving downstream rapamycin binding domain (42, 43, 64 – 67), the molecular of PI3K, we found that tuberous sclerosis complex (TSC) suppresses and Rheb promotes raptordetails of rapamycin-mediated mTOR inhibition remain associated mTOR Ser(P)-2481

Read more

Summary

Introduction

The evolutionarily conserved mammalian target of rapamycin (mTOR)4 protein kinase functions as an environmental sensor, integrating signals from diverse cellular stimuli to control cellular physiology [1,2,3]. mTOR signals in at least two distinct multiprotein complexes distinguished by their partner proteins and differing sensitivities to rapamycin, a clinically employed immunosuppressive drug and allosteric mTOR inhibitor [4, 5]. These data indicate that in HEK293 cells and 3T3-L1 adipocytes, rapamycin inhibits mTORC1-associated mTOR Ser-2481 autophosphorylation. In HEK293 cells, strong mTORC1-associated mTOR Ser(P)-2481 was observed as early as 5 min after insulin stimulation, before maximal phosphorylation of downstream substrates (e.g. S6), and was maintained for up to 2 h (supplemental Fig. S5).

Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call